Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $91,064 | 37 | 72.5% |
| Travel and Lodging | $22,580 | 28 | 18.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,300 | 1 | 5.0% |
| Honoraria | $2,550 | 3 | 2.0% |
| Food and Beverage | $2,311 | 27 | 1.8% |
| Unspecified | $875.00 | 2 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $60,522 | 57 | $0 (2024) |
| Amgen Inc. | $33,677 | 9 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $15,284 | 17 | $0 (2022) |
| Omeros Corporation | $6,250 | 3 | $0 (2021) |
| Chiesi USA, Inc. | $4,055 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $2,486 | 3 | $0 (2020) |
| Medexus Pharma, Inc. | $2,040 | 1 | $0 (2024) |
| Leadiant Biosciences, Inc. | $875.00 | 2 | $0 (2020) |
| Apellis Pharmaceuticals, Inc. | $250.00 | 1 | $0 (2022) |
| VERTEX PHARMACEUTICALS INCORPORATED | $220.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,840 | 3 | Medexus Pharma, Inc. ($2,040) |
| 2023 | $17,404 | 13 | Alexion Pharmaceuticals, Inc. ($16,809) |
| 2022 | $17,353 | 7 | Amgen Inc. ($16,277) |
| 2021 | $28,315 | 12 | Amgen Inc. ($15,200) |
| 2020 | $7,199 | 7 | Omeros Corporation ($3,850) |
| 2019 | $32,884 | 26 | Alexion Pharmaceuticals, Inc. ($29,157) |
| 2018 | $6,852 | 11 | Alexion Pharmaceuticals, Inc. ($4,204) |
| 2017 | $12,831 | 19 | Jazz Pharmaceuticals Inc. ($6,148) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 05/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $780.00 | General |
| Category: Rare Disease | ||||||
| 01/09/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $20.32 | General |
| 07/20/2023 | Chiesi USA, Inc. | REVCOVI (Drug) | Consulting Fee | Cash or cash equivalent | $595.00 | General |
| Category: ERT FOR ADA-SCID | ||||||
| 05/10/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,700.00 | General |
| 04/24/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $709.43 | General |
| 04/24/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $59.41 | General |
| 04/24/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $50.20 | General |
| 04/23/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $9.28 | General |
| 04/22/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $21.89 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $3,868.95 | General |
| 04/20/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $170.90 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.72 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $111.23 | General |
| 02/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $91.48 | General |
| 09/29/2022 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $759.50 | General |
| 08/31/2022 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Hematology | ||||||
| 04/24/2022 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $66.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/07/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,600.00 | General |
| 02/22/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,400.00 | General |
| 01/18/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $6,200.00 | General |
| 01/18/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $76.67 | General |
| 11/22/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 09/27/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (elpegademase-lvlr) Treatment in ADA-SCID Subjects Requiring Enzyme Replacement Therapy | Leadiant Biosciences, Inc. | $875.00 | 2 |
About Dr. Christopher Dvorak, MD
Dr. Christopher Dvorak, MD is a Pediatric Hematology-Oncology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861527657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Dvorak, MD has received a total of $125,679 in payments from pharmaceutical and medical device companies, with $2,840 received in 2024. These payments were reported across 98 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($91,064).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Palo Alto, CA
- Active Since 02/22/2007
- Last Updated 03/24/2008
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1861527657
Products in Payments
- SOLIRIS (Drug) $37,683
- Defitelio (Drug) $8,796
- DEFITELIO (Drug) $6,488
- Narsoplimab (Drug) $3,850
- FERRIPROX (Drug) $2,700
- Revcovi (Biological) $875.00
- ULTOMIRIS (Biological) $780.00
- REVCOVI (Drug) $595.00
- Empaveli (Drug) $250.00
- Soliris (Drug) $150.00
- Ultomiris (Drug) $150.00
- KYMRIAH (Biological) $124.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Palo Alto
Philip Pizzo, Md, MD
Pediatric Hematology-Oncology — Payments: $2.6M
Dr. John Curnutte, M.d., Ph.d, M.D., PH.D
Pediatric Hematology-Oncology — Payments: $49,859
Bertil Glader, Md, MD
Pediatric Hematology-Oncology — Payments: $47,480
Glaivy Batsuli, Md, MD
Pediatric Hematology-Oncology — Payments: $43,490
Michael Link, Md, MD
Pediatric Hematology-Oncology — Payments: $42,188
Orly Klein, Md, MD
Pediatric Hematology-Oncology — Payments: $31,152